HealthRX.com · Printable symptom log
Numbness and tingling log with emergency signs on the page
Record where the numbness is, how it feels, whether it is spreading, and what you injected or took that day, plus the background a clinician will ask about. The emergency signs at the top mean stop logging and get care now.
Stop logging and get emergency care
- Weakness or being unable to move, along with numbness or tingling: go to a hospital or call 911.[1]
- Losing control of an arm or leg, or of bladder or bowel.[1]
- Slurred speech, a change in vision, or difficulty walking.[1]
- Weakness that starts in the feet and moves up the body.[2]
Background your clinician will ask about
Peptide or medicine started, with source and start date
Metformin or other long-term medicines
Diabetes or prediabetes; recent glucose or HbA1c
Weight lost recently and over how long
Alcohol use, work exposures, recent infection
Daily entries
| Date | Where (one side, both sides, injection spot) | Numb, tingling, burning or painful? | Spreading since last entry? | Weakness or balance change? | Injection or new product that day |
|---|---|---|---|---|---|
What the first visit may check
- MedlinePlus lists glucose screening for diabetes and vitamin levels, particularly vitamin B12, among the blood tests a provider may order.[1]
- For symmetric feet-first neuropathy, the AAN found the highest-yield screening tests were blood glucose, B12 with methylmalonic acid, and serum protein immunofixation (a Level C recommendation).[3]
- Expect questions about stroke, thyroid and diabetes risk, your work and your medicines.[1]
Sources for the facts on this sheet
- U.S. National Library of Medicine. Numbness and tingling: MedlinePlus Medical Encyclopedia. Accessed 2026-10-18. https://medlineplus.gov/ency/article/003206.htm
- National Institute of Neurological Disorders and Stroke. Guillain-Barré Syndrome. Accessed 2026-10-18. https://www.ninds.nih.gov/health-information/disorders/guillain-barre-syndrome
- England JD, Gronseth GS, Franklin G, et al. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009. PMID 19056666. https://pubmed.ncbi.nlm.nih.gov/19056666/
This sheet records information for a conversation with your prescriber or pharmacist. It does not replace their instructions or the medication's prescribing information.